Access cutting-edge dry age-related macular degeneration treatment through this clinical trial at a research site in Mcallen. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Mcallen location
Preparing your pre-screening questions…
Access dry age-related macular degeneration specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related dry age-related macular degeneration treatment provided free
Check if you qualify for this dry age-related macular degeneration clinical trial in Mcallen, TX
No-Cost Study Care
Local to Mcallen
Convenient for TX residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
The purpose of this registry study is to collect real life data pertaining to the safety and clinical effectiveness of multi-wavelength photobiomodulation (PBM) as provided by the Valeda Light Delivery System in participants with dry age-related macular degeneration (AMD) in routine clinical practice. Data will be collected retrospectively and prospectively. PBM involves the use of visible light to near infrared light (NIR) (500-1000 nanometers) produced by a laser or a non-coherent light source applied to the surface of the body to activate mitochondrial respiratory chain components, stabilize metabolic function, and promote cellular proliferation. This registry study will be conducted in Europe, the US, and select other countries approved by their regulatory agency. This registry study was initiated as a combined retrospective and prospective data collection effort. After the acquisition of LumiThera by Alcon Research, LLC in September 2025, the study was amended to prospectively collect data from U.S. sites starting in July 2026.
Sponsor: LumiThera, Inc.
Yes, this clinical trial (NCT06351605) has an active research site in Mcallen, TX that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for dry age-related macular degeneration treatment options in Mcallen, TX, this clinical trial (NCT06351605) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Mcallen research site is actively enrolling participants for this clinical trial. You'll receive care from experienced dry age-related macular degeneration specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all dry age-related macular degeneration clinical trials near you to find additional studies recruiting in your area.
See all rheumatoid arthritis clinical trials recruiting in Mcallen — not just this study.
Browse Rheumatoid Arthritis Trials in Mcallen →